Colorado BioScience Association: Industry raised $2.15B in 2024

DENVER — Colorado life-sciences companies raised $2.15 billion from investors in 2024, according to a report from the Colorado BioScience Association.

The fundraising haul is the second-largest over the last eight years, behind only the $2.4 billion raised by the industry in 2021. 

“Colorado companies raised $818.5 million in public capital, a 64% increase compared to 2023 through post-IPO equity and debt, $445.0 million through mergers, acquisitions, and partnerships, and $383.0 million in private capital, primarily from venture funding,” the CBSA report said. 

Since 2017, biotech companies have “attracted close to $12 billion for life sciences research and development” from investors, the trade organization said. 

“Investors know there’s a unique and powerful convergence of world-changing technologies being developed in Colorado, with life sciences playing an interconnected role,” CBSA CEO Elyse Blazevich said in a prepared statement. “Life sciences investors, companies, and talent are seeing and seizing the opportunities in Colorado because of our collaborative community, top-ranked talent, central location, robust infrastructure, reasonable costs, and unmatched quality of life. It’s no surprise Colorado now ranks in the top quintile for life sciences venture capital funding.”  

This article was first published by BizWest, an independent news organization, and is published under a license agreement. © 2024 BizWest Media LLC.

on Facebook on LinkedIn